Boden, G., and Hoeldtke, R.D.Making intensified insulin treatment safer. Annals of Internal Medicine, 1983, 99, 268-269.
2.
Boden, G., Reichard, G.A., Jr. , Hoeldtke, R.D., Rezvani, I., and Owen, O.E.Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. The New England Journal of Medicine, 1981, 305, 1200-1205.
3.
Gerich, J., Davis, J., Lorenzi, M., Rizza, R., Bohannon, N., Karam, J., Lewis, S., Kaplan, R., Schultz, T., and Cryer, P.Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. American Journal of Physiology, 1979, 236(4), E380-E385.
4.
Hoeldtke, R.D., Boden, G., Shuman, C.R., and Owen, O.E.Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Annals of Internal Medicine , 1982, 96, 459-462.
5.
Polonsky, K., Bergenstal, R., Pons, G., Schneider, M., Jaspan, J., and Rubenstein, A.R.Relations of counterregulatory responses to hypoglycemia in Type I diabetics, New England Journal of Medicine, 1982, 307, 1106-1112.
6.
White, N.H., Skor, D.A., Cryer, D.E., Levandoski, L.A., Bier, D.M., Santiago, J.V.Identification of Type I diabetic patients at increased risk for hypoglycemia during intensive therapy. New England Journal of Medicine, 1983, 308, 485-491.
7.
Wilson, D.E.Excessive insulin therapy; chemical effects and clinical reproductions — current concepts of counterregulation in Type I diabetes. Annals of Internal Medicine, 1983, 98, 219-227.
